Counting the Toll of Inflammation on Schizophrenia-A Potential Role for Toll-like Receptors.


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
30 07 2023
Historique:
received: 16 05 2023
revised: 25 07 2023
accepted: 25 07 2023
medline: 28 8 2023
pubmed: 26 8 2023
entrez: 26 8 2023
Statut: epublish

Résumé

Toll-like receptors (TLRs) are a family of pattern recognition receptors (PRRs) that are ubiquitously expressed in the human body. They protect the brain and central nervous system from self and foreign antigens/pathogens. The immune response elicited by these receptors culminates in the release of cytokines, chemokines, and interferons causing an inflammatory response, which can be both beneficial and harmful to neurodevelopment. In addition, the detrimental effects of TLR activation have been implicated in multiple neurodegenerative diseases such as Alzheimer's, multiple sclerosis, etc. Many studies also support the theory that cytokine imbalance may be involved in schizophrenia, and a vast amount of literature showcases the deleterious effects of this imbalance on cognitive performance in the human population. In this review, we examine the current literature on TLRs, their potential role in the pathogenesis of schizophrenia, factors affecting TLR activity that contribute towards the risk of schizophrenia, and lastly, the role of TLRs and their impact on cognitive performance in schizophrenia.

Identifiants

pubmed: 37627253
pii: biom13081188
doi: 10.3390/biom13081188
pmc: PMC10452856
pii:
doi:

Substances chimiques

Toll-Like Receptors 0
Cytokines 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Pediatr Res. 2007 Jan;61(1):15-20
pubmed: 17211134
J Clin Med. 2021 Jun 04;10(11):
pubmed: 34199832
Front Cell Neurosci. 2018 Oct 02;12:329
pubmed: 30333729
Eur Neuropsychopharmacol. 2021 Nov;52:48-61
pubmed: 34261013
Am J Pathol. 2011 Jun;178(6):2802-10
pubmed: 21641402
Psychiatry Res. 2019 Mar;273:369-377
pubmed: 30682559
Schizophr Res. 2016 Sep;176(1):23-35
pubmed: 25034760
Immunol Invest. 2022 Oct;51(7):2009-2024
pubmed: 35815676
Nutrients. 2020 Oct 26;12(11):
pubmed: 33114561
Eur Cytokine Netw. 2000 Sep;11(3):362-71
pubmed: 11022119
Immunity. 2018 Sep 18;49(3):397-412
pubmed: 30231982
Mol Brain. 2012 Jun 09;5:22
pubmed: 22681877
J Immunol. 2003 Sep 15;171(6):3154-62
pubmed: 12960343
J Neuropathol Exp Neurol. 2002 Nov;61(11):1013-21
pubmed: 12430718
Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):588-93
pubmed: 9435236
J Neuroinflammation. 2017 Nov 2;14(1):212
pubmed: 29096641
Front Immunol. 2019 May 31;10:1209
pubmed: 31214180
J Mol Neurosci. 2006;29(3):185-94
pubmed: 17085778
Front Psychiatry. 2022 Apr 25;13:880568
pubmed: 35546942
Nat Rev Immunol. 2020 Feb;20(2):95-112
pubmed: 31558839
Brain Behav Immun. 2021 Oct;97:383-393
pubmed: 34343615
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jul 1;44:301-11
pubmed: 23587629
Biol Psychiatry. 2007 Oct 1;62(7):711-21
pubmed: 17568569
J Psychiatry Neurosci. 2016 Apr;41(3):E46-55
pubmed: 27070349
Front Psychiatry. 2022 Aug 16;13:966657
pubmed: 36051545
Cell. 2010 Mar 19;140(6):805-20
pubmed: 20303872
Nat Immunol. 2001 Aug;2(8):675-80
pubmed: 11477402
Soc Sci Med. 2013 Nov;97:259-66
pubmed: 23313495
PLoS One. 2010 Aug 16;5(8):e12191
pubmed: 20808947
Psychiatry Res. 2020 Mar;285:112727
pubmed: 31837816
Behav Brain Res. 2022 May 24;426:113836
pubmed: 35278481
Arch Gen Psychiatry. 2001 Nov;58(11):1032-7
pubmed: 11695949
J Clin Endocrinol Metab. 2014 Jan;99(1):39-48
pubmed: 24187406
PLoS One. 2012;7(12):e52899
pubmed: 23300810
Front Immunol. 2020 Oct 15;11:582825
pubmed: 33178212
Brain Behav Immun. 2016 Aug;56:310-24
pubmed: 27044334
Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79(Pt B):481-492
pubmed: 28803924
Biol Psychiatry. 2011 Oct 1;70(7):663-71
pubmed: 21641581
Brain Behav Immun. 2019 Jul;79:152-158
pubmed: 30685531
J Immunol. 2012 Aug 1;189(3):1448-58
pubmed: 22745379
Front Immunol. 2014 Sep 25;5:461
pubmed: 25309543
Mol Psychiatry. 2016 Dec;21(12):1696-1709
pubmed: 26903267
Dev Psychopathol. 2001 Fall;13(4):759-82
pubmed: 11771907
Eur Neuropsychopharmacol. 2019 Mar;29(3):384-396
pubmed: 30630651
Prog Neuropsychopharmacol Biol Psychiatry. 2015 Jun 3;59:21-30
pubmed: 25554435
Eur J Microbiol Immunol (Bp). 2012 Sep;2(3):239-48
pubmed: 24688771
J Neuroinflammation. 2012 Apr 30;9:83
pubmed: 22546005
Front Psychiatry. 2020 Feb 26;11:72
pubmed: 32174851
Prog Neuropsychopharmacol Biol Psychiatry. 2018 Feb 2;81:477-487
pubmed: 28431901
Curr Med Sci. 2021 Aug;41(4):788-802
pubmed: 34403105
Am J Addict. 2015 Oct;24(7):586-9
pubmed: 26332037
J Immunol. 2005 Oct 1;175(7):4320-30
pubmed: 16177072
Br J Nutr. 2012 Jan;107(2):229-41
pubmed: 21733316
J Neurochem. 2021 Jan;156(2):249-261
pubmed: 32891068
Psychiatry Res. 2019 Feb;272:540-550
pubmed: 30616121
J Neurochem. 2021 Jul;158(2):328-341
pubmed: 33871050
J Neuroinflammation. 2017 Sep 18;14(1):188
pubmed: 28923068
Nat Rev Immunol. 2013 Jun;13(6):453-60
pubmed: 23681101
Neuropharmacology. 2017 Apr;116:196-207
pubmed: 28039001
Nat Immunol. 2010 May;11(5):373-84
pubmed: 20404851
Ann Agric Environ Med. 2013;20(3):465-86
pubmed: 24069851
Brain Behav Immun. 2021 Nov;98:388-396
pubmed: 34242739
Biomolecules. 2019 Dec 19;10(1):
pubmed: 31861745
Annu Rev Public Health. 2011;32:237-62
pubmed: 21219171
Int J Mol Sci. 2020 Aug 25;21(17):
pubmed: 32854231
Front Mol Neurosci. 2017 Dec 12;10:409
pubmed: 29311802
Schizophr Res. 2012 Jun;138(1):48-53
pubmed: 22446142
Schizophr Bull. 2019 Sep 11;45(5):1112-1119
pubmed: 30462333
JAMA Psychiatry. 2022 May 1;79(5):498-507
pubmed: 35353173
Immunol Res. 2021 Dec;69(6):541-552
pubmed: 34546527
Cell Rep. 2021 Mar 23;34(12):108891
pubmed: 33761354
Curr Opin Lipidol. 2009 Oct;20(5):379-85
pubmed: 19625959
Gene. 1999 Apr 29;231(1-2):59-65
pubmed: 10231569
Front Psychiatry. 2021 Feb 17;12:585742
pubmed: 33679468
Behav Brain Res. 2009 Dec 7;204(2):313-21
pubmed: 19136031
J Biomed Sci. 2019 Nov 4;26(1):90
pubmed: 31684953
Immune Netw. 2018 Aug 13;18(4):e27
pubmed: 30181915
Biol Pharm Bull. 2005 May;28(5):886-92
pubmed: 15863899
Psychiatry Res. 2011 May 30;187(3):341-6
pubmed: 20510460
Neurosci Res. 2009 Jul;64(3):297-305
pubmed: 19447299
Nature. 2000 Aug 17;406(6797):782-7
pubmed: 10963608
Psychiatry Res. 2012 Aug 15;198(3):341-6
pubmed: 22429483
BMC Psychiatry. 2012 Dec 05;12:221
pubmed: 23216941
Biomed Res Int. 2021 Sep 12;2021:1157023
pubmed: 34552981
Int J Neuropsychopharmacol. 2014 Oct 31;18(3):
pubmed: 25522409
Schizophr Bull. 2009 Sep;35(5):959-72
pubmed: 18408229
J Neurosci. 2013 Jul 10;33(28):11479-93
pubmed: 23843519
Environ Health. 2019 Oct 15;18(1):85
pubmed: 31615514
Brain Behav Immun. 2014 Nov;42:212-21
pubmed: 25014010
Cells. 2021 Aug 31;10(9):
pubmed: 34571909
Biochim Biophys Acta. 2001 Mar 19;1518(1-2):157-61
pubmed: 11267672
Curr Opin Immunol. 2002 Feb;14(1):103-10
pubmed: 11790539
J Infect Dis. 2002 Sep 15;186(6):798-806
pubmed: 12198614
Brain Behav Immun. 2019 Aug;80:66-72
pubmed: 30807839
J Affect Disord. 2016 Oct;203:14-21
pubmed: 27285722
J Mol Psychiatry. 2014 Jun 27;2(1):4
pubmed: 25408914
Gene. 2013 Sep 10;526(2):182-6
pubmed: 23644137
Biol Psychiatry. 2018 Mar 15;83(6):492-498
pubmed: 28987712
Transl Psychiatry. 2011 Aug 30;1:e36
pubmed: 22832610
Neurosci Lett. 2022 Apr 23;777:136581
pubmed: 35337952
Brain Behav Immun. 2015 Aug;48:301-12
pubmed: 26021559
Brain Behav Immun. 2012 Aug;26(6):880-5
pubmed: 22401992
Schizophr Res. 2019 Apr;206:300-306
pubmed: 30429077
Innate Immun. 2014 Feb;20(2):161-72
pubmed: 23751821
mBio. 2010 Oct 05;1(4):
pubmed: 20941330
Proc Natl Acad Sci U S A. 2007 Aug 21;104(34):13798-803
pubmed: 17693552
Curr Genomics. 2012 Dec;13(8):633-45
pubmed: 23730203
Prog Neuropsychopharmacol Biol Psychiatry. 2023 Mar 8;121:110668
pubmed: 36283512
Cell. 1996 Sep 20;86(6):973-83
pubmed: 8808632
Mol Psychiatry. 2006 Jan;11(1):47-55
pubmed: 16189509
Schizophr Res. 2018 Feb;192:340-344
pubmed: 28655480
Kaohsiung J Med Sci. 2020 Sep;36(9):721-731
pubmed: 32627922
Clin Lab. 2016;62(4):535-44
pubmed: 27215071
Brain Res Bull. 2018 Mar;137:53-70
pubmed: 29137928
J Lipid Res. 2003 Mar;44(3):479-86
pubmed: 12562875
J Cell Biol. 2006 Oct 23;175(2):209-15
pubmed: 17060494
Neurobiol Learn Mem. 2018 Nov;155:379-389
pubmed: 30195050
Brain Behav Immun. 2017 May;62:256-264
pubmed: 28003154
J Chem Neuroanat. 2021 Dec;118:102035
pubmed: 34597812
J Biol Chem. 2004 Apr 23;279(17):16971-9
pubmed: 14966134
Mol Psychiatry. 2017 Feb;22(2):257-266
pubmed: 27843150
J Cereb Blood Flow Metab. 2013 Jan;33(1):13-21
pubmed: 23072749
Neuroreport. 2016 Mar 2;27(4):224-9
pubmed: 26765791
Nat Rev Immunol. 2004 Jul;4(7):499-511
pubmed: 15229469
Am J Psychiatry. 1994 Jun;151(6 Suppl):182-7
pubmed: 8192197
Curr Pharm Des. 2016;22(40):6122-6133
pubmed: 27604609
Schizophr Bull. 2021 Aug 21;47(5):1243-1253
pubmed: 33761534
Signal Transduct Target Ther. 2021 Aug 4;6(1):291
pubmed: 34344870
J Neurosci. 2002 Apr 1;22(7):2478-86
pubmed: 11923412
Glia. 2001 Nov;36(2):180-90
pubmed: 11596126
J Neuroinflammation. 2018 Oct 22;15(1):295
pubmed: 30348171
Brain Behav Immun. 2001 Dec;15(4):411-20
pubmed: 11782107
J Neuroimmunol. 2005 Feb;159(1-2):12-9
pubmed: 15652398
J Interferon Cytokine Res. 2013 Sep;33(9):467-84
pubmed: 23675778
J Immunol. 2005 Mar 15;174(6):3719-26
pubmed: 15749911
Eur J Endocrinol. 2013 Feb 20;168(3):419-27
pubmed: 23230212
Brain Behav Immun. 2014 Mar;37:142-51
pubmed: 24321214
PLoS One. 2019 Aug 12;14(8):e0220560
pubmed: 31404078
Schizophr Res. 2013 Dec;151(1-3):43-7
pubmed: 24200418
Diabetologia. 2016 Nov;59(11):2459-2466
pubmed: 27535280
Sci Rep. 2017 Jun 23;7(1):4147
pubmed: 28646138
Nature. 1997 Jul 24;388(6640):394-7
pubmed: 9237759
J Psychiatr Res. 2023 Apr;160:126-136
pubmed: 36804109
Brain Res. 2010 Dec 2;1363:170-9
pubmed: 20863817
Arch Gen Psychiatry. 1989 Oct;46(10):878-82
pubmed: 2802927
Cell. 1985 Oct;42(3):779-89
pubmed: 3931918
J Virol. 2005 Oct;79(20):12893-904
pubmed: 16188991
Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082
pubmed: 29126136
Sci Rep. 2015 Feb 17;5:8502
pubmed: 25687169
Schizophr Res. 2012 Aug;139(1-3):161-8
pubmed: 22704639
Eur J Pharmacol. 2014 Dec 15;745:166-75
pubmed: 25218983

Auteurs

Saahithh Redddi Patlola (SR)

Department of Pharmacology & Therapeutics, School of Medicine, University of Galway, H91 TK33 Galway, Ireland.

Gary Donohoe (G)

School of Psychology, University of Galway, H91 TK33 Galway, Ireland.

Declan P McKernan (DP)

Department of Pharmacology & Therapeutics, School of Medicine, University of Galway, H91 TK33 Galway, Ireland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH